REED ELIZABETH E (SVP, GC & Corporate Secretary) sold 8.7% of their position (10K shares) of TRAVERE THERAPEUTICS, INC. on the open market
Open‑market sale worth $300.0K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/2/2026ACC: 0001283303-26-000007
Officer· SVP, GC & Corporate Secretary
Since Nov 2018
-10K
Net shares
Net seller
$300.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10K acquired · 20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10K
Price / share
$15.46
Trade value
$154.60K
% of position
9.5%
4/1/2026
105.21K→115.21K
Common Stock
Direct
Shares
−10K
Price / share
$30.00
Trade value
$300K
% of position
8.7%
4/1/2026
115.21K→105.21K
Total
Net shares
+0.00
Net value
-$145.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2026 | M · Option Exercise | +10K | $15.46 | $154.60K | 9.5% | 105.21K | 115.21K |
| Common Stock Direct | 4/1/2026 | S · Sale | −10K | $30.00 | $300K | 8.7% | 115.21K | 105.21K |
| Total | +0.00 | -$145.40K | ||||||
Derivative Transactions1
Employee stock option (right to buy)
Direct
Converts to
Common Stock
10K shares
Shares
−10K
Strike price
15.46
Held after
45K
Exercisable
—
4/1/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee stock option (right to buy) Direct | Common Stock10K shares | 4/1/2026 | M · Option Exercise | −10K | 15.46 | — | 45K |